(19)
(11) EP 2 943 212 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
16.05.2018 Bulletin 2018/20

(45) Mention of the grant of the patent:
28.03.2018 Bulletin 2018/13

(21) Application number: 14700845.2

(22) Date of filing: 14.01.2014
(51) International Patent Classification (IPC): 
A61K 38/17(2006.01)
A61K 9/00(2006.01)
A61K 9/16(2006.01)
 A61P 9/10(2006.01)
C07K 14/47(2006.01)
(86) International application number:
PCT/EP2014/050533
(87) International publication number:
WO 2014/108549 (17.07.2014 Gazette 2014/29)

(54)

PHARMACEUTICAL COMPOSITIONS FOR CARDIOPROTECTION

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR KARDIOPROTEKTION

COMPOSITIONS PHARMACEUTIQUES POUR CARDIOPROTECTION

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 14.01.2013 EP 13305029

(43) Date of publication of application:
18.11.2015 Bulletin 2015/47

(73) Proprietors:
  • Institut National de la Santé et de la Recherche Médicale (INSERM)
    75013 Paris (FR)
  • UNIVERSITE DE MONTPELLIER
    34090 Montpellier (FR)
  • Assistance Publique Hôpitaux De Paris
    75004 Paris 4 (FR)
  • Université d'Angers
    49100 Angers (FR)
  • Université Paris-Est Créteil Val de Marne
    94000 Créteil (FR)

(72) Inventors:
  • LACAMPAGNE, Alain
    F-34295 Montpellier Cedex 05 (FR)
  • THIREAU, Jérôme
    F-34295 Montpellier Cedex 05 (FR)
  • CAZORLA, Olivier
    F-34295 Montpellier Cedex 5 (FR)
  • LE GUENNEC, Jean-Yves
    F-34295 Montpellier Cedex 5 (FR)
  • FAUCONNIER, Jérémy
    F-34295 Montpellier Cedex 5 (FR)
  • MARTINEZ, Maria Del Carmen
    F-49933 Angers Cedex 9 (FR)
  • ANDRIANTSITOHAINA, Ramaroson
    F-49933 Angers Cedex 9 (FR)
  • GALEH-MARZBAN, Bijan
    94700 Maisons-Alfort (FR)
  • SOLETI, Raffaella
    49100 Angers (FR)

(74) Representative: Hirsch, Denise Marie 
Inserm Transfert IP Department 7 rue Watt
75013 Paris
75013 Paris (FR)


(56) References cited: : 
WO-A2-02/080952
WO-A2-2007/047882
US-A1- 2012 244 136
 WO-A2-2005/028616
WO-A2-2008/115469
   
  • KAZUTAKA UEDA ET AL: "Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice", JOURNAL OF CLINICAL INVESTIGATION. ISSN: 0021-9738. PB - AMER SOC CLINICAL INVESTIGATION INC, 35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA., vol. 120, no. 6, June 2010 (2010-06), pages 2016-2029, XP009167705,
  • JEROME RONCALLI ET AL: "Sonic Hedgehog -Induced Functional Recovery After Myocardial Infarction is enhanced by AMD3100-Mediated Progenitor-Cell Mobilization", JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN: 0735-1097. PB - ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA., vol. 57, no. 24, 14 June 2011 (2011-06-14) , pages 2444-2452, XP009167706,
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).